中文 | English
Return
Total: 277 , 1/28
Show Home Prev Next End page: GO
Author:(Na-Ying CHEN)

1.Expression and clinical significance of cyclooxygenase-2 in multiple myeloma

Ying HU ; Shilun CHEN ; Xiaonan HUANG ; Na AN

Journal of Leukemia & Lymphoma 2008;17(5):337-339

3.The Value of Ultrasonography in the Diagnosis of Idiopathic Retroperitoneal Fibrosis

Chunguang WANG ; Yantao CHEN ; Guirong WANG ; Ying NA

Chinese Journal of Medical Imaging 2010;(1):72-74

4.Study of gonadal hormone drugs in blocking filovirus entry of cells in vitro.

Li-li WANG ; Qing CHEN ; Li-na ZHOU ; Ying GUO

Acta Pharmaceutica Sinica 2015;50(12):1545-1550

5.The clinical analysis of tension-free hernia repair in inguinal emergency hernia

Dong-Ming NA ; Jie CHEN ; Ying-Mo SHEN ;

Chinese Journal of Primary Medicine and Pharmacy 2005;0(11):-

6.Study on Relationship between Dopamine D1 Receptor Gene Polymorphisms and Clozapine Efficacy in Male Schizophrenic Patients

Ying CHEN ; Na WU ; Falin QU ; Yuan WEI ; Haiying YU ; Guangjian WANG ; Fangbin CHEN

China Pharmacist 2014;(12):1993-1995,1996

7.Malignant pleural effusion of multiple myeloma

Jiajia ZHANG ; Yuping ZHONG ; Xin LI ; Ying HU ; Na AN ; Xiaohui LIU ; Shilun CHEN

Journal of Leukemia & Lymphoma 2010;19(7):407-409

8.Low-Field-MRI in Assessing the Vessels Surrounding Pancreas Involved by Pancreatic Carcinoma

Shouqiang JIA ; Yongxiu WANG ; Qingguo LI ; Ying CHEN ; Na LI ; Huizhen SUN

Journal of Practical Radiology 2001;0(08):-

9.The mechanism of alteronol inhibiting the proliferation of human promyelocytic leukemia HL-60 cells.

Liangliang LIU ; Na CHEN ; Xuan YUAN ; Ying YAO ; Bo ZHANG ; Qiusheng ZHENG

Acta Pharmaceutica Sinica 2012;47(11):1477-82

10.Expression of periostin in the kidneys of rats with obstructive nephropathy and its significance

Baoping BIAN ; Ying WAN ; Rong CHEN ; Chunmei ZHANG ; Hua TANG ; Na LUO ; Ping ZOU

Chinese Journal of Nephrology 2012;28(8):628-632

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 277 , 1/28 Show Home Prev Next End page: GO